BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies

A Alu, H Lei, X Han, Y Wei, X Wei - Journal of Hematology & Oncology, 2022 - Springer
Bruton's tyrosine kinase (BTK) is an essential component of multiple signaling pathways that
regulate B cell and myeloid cell proliferation, survival, and functions, making it a promising …

Bruton tyrosine kinase inhibitors for multiple sclerosis

J Krämer, A Bar-Or, TJ Turner, H Wiendl - Nature Reviews Neurology, 2023 - nature.com
Current therapies for multiple sclerosis (MS) reduce both relapses and relapse-associated
worsening of disability, which is assumed to be mainly associated with transient infiltration of …

Role of Bruton's tyrosine kinase in B cells and malignancies

S Pal Singh, F Dammeijer, RW Hendriks - Molecular cancer, 2018 - Springer
Bruton's tyrosine kinase (BTK) is a non-receptor kinase that plays a crucial role in oncogenic
signaling that is critical for proliferation and survival of leukemic cells in many B cell …

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

SP Treon, JJ Castillo, AP Skarbnik… - Blood, The Journal …, 2020 - ashpublications.org
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
| Blood | American Society of Hematology Skip to Main Content Advertisement Umbrella Alt …

Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury

M Ito, T Shichita, M Okada, R Komine… - Nature …, 2015 - nature.com
Inflammasome activation has been implicated in various inflammatory diseases including
post-ischaemic inflammation after stroke. Inflammasomes mediate activation of caspase-1 …

Targeting Bruton's tyrosine kinase in B cell malignancies

RW Hendriks, S Yuvaraj, LP Kil - Nature Reviews Cancer, 2014 - nature.com
Bruton's tyrosine kinase (BTK) is a key component of B cell receptor (BCR) signalling and
functions as an important regulator of cell proliferation and cell survival in various B cell …

Bruton's tyrosine kinase: an emerging key player in innate immunity

ANR Weber, Z Bittner, X Liu, TM Dang… - Frontiers in …, 2017 - frontiersin.org
Bruton's tyrosine kinase (BTK) was initially discovered as a critical mediator of B cell
receptor signaling in the development and functioning of adaptive immunity. Growing …

The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic …

ZR Hunter, L Xu, G Yang, Y Zhou, X Liu… - Blood, The Journal …, 2014 - ashpublications.org
The genetic basis for Waldenström macroglobulinemia (WM) remains to be clarified.
Although 6q losses are commonly present, recurring gene losses in this region remain to be …

LPS-induced cytokine production in human monocytes and macrophages

M Rossol, H Heine, U Meusch, D Quandt… - Critical Reviews™ in …, 2011 - dl.begellhouse.com
Lipopolysaccharide (LPS) from Gram-negative bacteria is one of the most potent innate
immune-activating stimuli known. Here we review the current understanding of LPS effects …

Toll-like receptor signalling

S Akira, K Takeda - Nature reviews immunology, 2004 - nature.com
One of the mechanisms by which the innate immune system senses the invasion of
pathogenic microorganisms is through the Toll-like receptors (TLRs), which recognize …